Haben Sie eine Frage oder möchten Sie einen Termin vereinbaren?
Gerne rufen wir Sie an oder melden uns per E-Mail bei Ihnen. Wie möchten Sie kontaktiert werden?
Das rivr Team bedankt sich für Ihr Interesse.
Wir werden uns schnellstmöglich mit Ihnen in Verbindung setzen.
Vanessa strongly believes that the foundation of our health is nutrition and ageing well starts from within. For more than a decade, Formettā founder and biomedical research doctor Vanessa Craig actively researched how inflammation and environmental factors influence gene activity and chronic disease development. Through her research she discovered how nutrition and supplementing wisely could be the secret to improved health and graceful ageing.
Dr. Craig began her studies at the University of Sydney, where she completed a BSc in Molecular Biology and Genetics, with Honours in Biochemistry. She graduated summa cum laude with a PhD in molecular oncology from the University of Zürich, where she also patented two targeted cancer therapies. At the Novartis Institute of Biomedical Research, Dr. Craig was awarded a fellowship to continue her research in epigenetics. Through her own personal struggle with health she became interested in how nutrition, among other lifestyle factors, impacts our health and longevity. She studied Nutrition Science at the School of Medicine at Stanford University to sharpen her knowledge further and gain a more holistic understanding of the interplay between nutrition, ageing, and overall health.
Her studies, research, and personal experience increased Dr. Craig’s fascination with the powers of collagen—prompting her to develop the formula for Formettā, an advanced daily collagen supplement. Dr. Craig enjoys creating and leading workshops to assist groups in understanding the importance of eating a nutrient dense diet and how to achieve optimal health via nutrition. Understanding the individual nature of health is the crux of Vanessa’s nutrition philosophy. There is not one program or approach that suits all. Her one-on-one consultations therefore provide the ultimate key to get to the root of her clients health issues and accomplish their well-being goals. Originally from Australia, she lives in Zurich with her husband and two children
|2019 Nutrition Science Course, Stanford University, Professor Christopher Gardner|
|2016 Founder and CEO at Formetta Gmbh, Zurich Switzerland.|
|2014 Drug discovery & development project simulation, Novartis Institute for Biomedical research (NIBR)|
|2013 Novartis leadership program, Novartis Institute for Biomedical research (NIBR)|
|2012 Presidential Postdoctoral Fellow, Novartis Institute for Biomedical research (NIBR) Basel, Switzerland.|
|2011 Postdoctoral Research Fellow, Group of Prof. Anne Müller, Institute of Molecular Cancer Research, University of Zürich, Switzerland|
|2010 Novartis Biotechnology Leadership Camp 2010|
|2009 Scientific Ethics Course, Life Science Zürich Graduate School (ETH/University of Zürich)|
|2008 Molecular and Cell Biology of Cancer Course, Life Science Zürich Graduate School (ETH/University of Zürich)|
|2008 Clinical Cancer Research Course, Life Science Zürich Graduate School (ETH/ University of Zürich)|
|2008 Laboratory Animal Science Course, Life Science Zürich Graduate School (ETH/ University of Zürich)|
|2007 PhD in Cancer Biology, Group of Prof. Anne Müller, University of Zürich, Switzerland.|
|2007 Life Science Zurich Graduate School, ETH |University Zurich Member of the Cancer Biology PhD Program|
|2006 Research Associate, Group of Prof. Jacqui Matthews, School of Molecular Biosciences, University of Sydney, Australia|
|2006 Honours in Biochemistry, Group of Prof. Jacqui Matthews, School of Molecular Biosciences, University of Sydney, Australia|
|2002 BSc Molecular Biology and Genetics, University of Sydney, Australia|
|Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia. |
Dafflon C*, Craig VJ* et al (2017)
Leukemia. doi: 10.1038/leu.2016.327 *equal contributing authors
|Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth. |
Harbinski F*, Craig VJ* et al (2012)
Cancer Discovery. 2012 Sep 26. *equal contributing authors
|Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B- cell lymphoma in vivo.|
Craig VJ, Tzankov A, Flori M, Schmid C A, Bader AG and Müller A. (2012)
Leukemia. doi: 10.1038/leu.2012.110.
|Epigenetic silencing of miRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. |
Craig VJ, Cogliatti SB, Rehrauer H, Wündisch T and Müller A. (2011)
Cancer Research. 71(10):3616-24.
|Myc-mediated repression of microRNA-34a promotes high grade transformation of gastric B-cell lymphoma by dysregulation of FoxP1. |
Craig VJ, Cogliatti SB, Neuenschwander S, Rehrauer H, Schlapbach R, Wündisch T, Tzankov A, Dirnhofer S and Müller A. (2011).
| B-cell receptor signaling and CD40 ligand-independent T-cell help cooperate in Helicobacter-induced MALT lymphomagenesis. |
Craig VJ, Cogliatti SB, Arnold I, Gerke C, Balanda JE, Wündisch T, Müller A. (2010).
Leukemia. 24, 1186-96.
|- Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. |
Craig VJ, Arnold I, Gerke C., Huynh MQ, Wundisch T, Neubauer A, Renner C, Falkow S, Mueller A. (2010).
| Competition between LIM binding domains. |
Matthews JM, Bhati M, Craig VJ, Deane JE, Lee C, Nancarrow AL, Ryan DP, Sunde M. (2008)
Biochem Soc Trans. Dec 36;(6): 1393-7
| Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes. |
Bhati M, Lee C, Nancarrow AL, Lee M, Craig VJ, Bach I, Guss JM, Mackay JP, Matthews JM. (2008)
EMBO J. Jul 23;27(14):2018-29.
|Treatment of ABL1 overexpressing B-cell lymphoma. |
Craig VJ and Müller A.
World Intellectual Property Publication: WO 2012/041959 A1, 5th April 2012
| Treatment of B-cell lymphoma with microRNA. |
Craig VJ and Müller A.
World Intellectual Property Publication: WO2012/035131 A1, 22nd March 2012
|2011||Young Investigator Award, Charles Rodolphe Brupbacher|
|2011||Summa cum laude,, prize for outstanding PhD thesis, Science Faculty, University of Zürich|
|2009||URPP Systems Biology/Functional Genomics Research Project Grant,|
|2008||URPP Systems Biology/Functional Genomics Research Project Grant|
|2006||Award of the University Medal,, University of Sydney|
|2006||Deans Honours List,, University of Sydney|
|2006||First Class Honours,, University of Sydney|
|2005||Gabriella Wittman Prize for Proficiency in Advanced Genetics|
|2005||Deans Honours List,, University of Sydney|
|2004||Deans Honours List,, University of Sydney|
|German (Advanced Level)|